Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Bioorg Med Chem ; 92: 117423, 2023 09 07.
Artigo em Inglês | MEDLINE | ID: mdl-37531921

RESUMO

Hematopoietic progenitor kinase 1 (HPK1) is regarded as a highly validated target in pre-clinical immune oncology. HPK1 has been described as regulating multiple critical signaling pathway in both adaptive and innate cells. In support of this role, HPK1 KO T cells show enhanced sensitivity to TCR activation and HPK1 KO mice display enhanced anti-tumor activity. Taken together, inhibition of HPK1 has the potential to induce enhanced anti-tumor immune response. Herein, we described the discovery of highly potent HPK1 inhibitors starting form a weak HTS hit. Using a structure-based drug design, HPK1 inhibitors exhibiting excellent cellular single-digit nanomolar potency in both proximal (pSLP76) and distal (IL-2) biomarkers along with sustained elevation of IL-2 cytokine secretion were discovered.


Assuntos
Interleucina-2 , Receptores de Antígenos de Linfócitos T , Camundongos , Animais , Chlorocebus aethiops , Proteínas Serina-Treonina Quinases , Células COS
2.
J Med Chem ; 64(19): 14603-14619, 2021 10 14.
Artigo em Inglês | MEDLINE | ID: mdl-34596404

RESUMO

Herein, we report the discovery of a novel class of quinazoline carboxamides as dual p70S6k/Akt inhibitors for the treatment of tumors driven by alterations to the PI3K/Akt/mTOR (PAM) pathway. Through the screening of in-house proprietary kinase library, 4-benzylamino-quinazoline-8-carboxylic acid amide 1 stood out, with sub-micromolar p70S6k biochemical activity, as the starting point for a structurally enabled p70S6K/Akt dual inhibitor program that led to the discovery of M2698, a dual p70S6k/Akt inhibitor. M2698 is kinase selective, possesses favorable physical, chemical, and DMPK profiles, is orally available and well tolerated, and displayed tumor control in multiple in vivo studies of PAM pathway-driven tumors.


Assuntos
Neoplasias , Inibidores de Proteínas Quinases , Proteínas Proto-Oncogênicas c-akt , Proteínas Quinases S6 Ribossômicas 70-kDa , Animais , Humanos , Linhagem Celular Tumoral , Ensaios de Triagem em Larga Escala , Neoplasias/tratamento farmacológico , Neoplasias/enzimologia , Neoplasias/metabolismo , Fosfatidilinositol 3-Quinases/efeitos dos fármacos , Inibidores de Proteínas Quinases/farmacologia , Inibidores de Proteínas Quinases/uso terapêutico , Proteínas Proto-Oncogênicas c-akt/antagonistas & inibidores , Proteínas Proto-Oncogênicas c-akt/metabolismo , Proteínas Quinases S6 Ribossômicas 70-kDa/antagonistas & inibidores , Proteínas Quinases S6 Ribossômicas 70-kDa/metabolismo , Transdução de Sinais/efeitos dos fármacos , Estereoisomerismo , Relação Estrutura-Atividade , Serina-Treonina Quinases TOR/efeitos dos fármacos
3.
Bioorg Med Chem Lett ; 50: 128352, 2021 10 15.
Artigo em Inglês | MEDLINE | ID: mdl-34481987

RESUMO

Activation of the PI3K/Akt/mTOR kinase pathway is associated with human cancers. A dual p70S6K/Akt inhibitor is sufficient to inhibit strong tumor growth and to block negative impact of the compensatory Akt feedback loop activation. A scaffold docking strategy based on an existing quinazoline carboxamide series identified 4-aminopyrimidine analog 6, which showed a single-digit nanomolar and a micromolar potencies in p70S6K and Akt enzymatic assays. SAR optimization improved Akt enzymatic and p70S6K cellular potencies, reduced hERG liability, and ultimately discovered the promising candidate 37, which exhibited with a single digit nanomolar value in both p70S6K and Akt biochemical assays, and hERG activities (IC50 = 17.4 µM). This agent demonstrated dose-dependent efficacy in inhibiting mice breast cancer tumor growth and covered more than 90% pS6 inhibition up to 24 h at a dose of 200 mg/kg po.


Assuntos
Antineoplásicos/farmacologia , Descoberta de Drogas , Neoplasias Mamárias Animais/tratamento farmacológico , Proteínas Proto-Oncogênicas c-akt/antagonistas & inibidores , Pirimidinas/farmacologia , Proteínas Quinases S6 Ribossômicas 70-kDa/antagonistas & inibidores , Animais , Antineoplásicos/química , Antineoplásicos/farmacocinética , Área Sob a Curva , Cães , Feminino , Meia-Vida , Haplorrinos , Camundongos , Simulação de Acoplamento Molecular , Estrutura Molecular , Proteínas Proto-Oncogênicas c-akt/genética , Proteínas Proto-Oncogênicas c-akt/metabolismo , Pirimidinas/química , Pirimidinas/farmacocinética , Ratos , Proteínas Quinases S6 Ribossômicas 70-kDa/genética , Proteínas Quinases S6 Ribossômicas 70-kDa/metabolismo , Relação Estrutura-Atividade , Serina-Treonina Quinases TOR/genética , Serina-Treonina Quinases TOR/metabolismo
4.
Bioorg Med Chem Lett ; 23(10): 3081-7, 2013 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-23570792

RESUMO

Several potent Aurora kinase inhibitors derived from 5H-benzo[c][1,8]naphthyridin-6-one scaffold were identified. A crystal structure of Aurora kinase A in complex with an initial hit revealed a binding mode of the inhibitor within the ATP binding site and provided insight for structure-guided compound optimization. Subsequent SAR campaign provided a potent and selective pan Aurora inhibitor, which demonstrated potent target modulation and antiproliferative effects in the pancreatic cell line, MIAPaCa-2. Furthermore, this compound inhibited phosphorylation of histone H3 (pHH3) in mouse bone morrow upon oral administration, which is consistent with inhibition of Aurora kinase B activity.


Assuntos
Aurora Quinases/antagonistas & inibidores , Naftiridinas/farmacologia , Inibidores de Proteínas Quinases/farmacologia , Administração Oral , Animais , Aurora Quinases/metabolismo , Linhagem Celular Tumoral , Cristalografia por Raios X , Relação Dose-Resposta a Droga , Histonas/antagonistas & inibidores , Histonas/metabolismo , Humanos , Camundongos , Modelos Moleculares , Estrutura Molecular , Naftiridinas/administração & dosagem , Naftiridinas/síntese química , Fosforilação/efeitos dos fármacos , Inibidores de Proteínas Quinases/administração & dosagem , Inibidores de Proteínas Quinases/síntese química , Relação Estrutura-Atividade
5.
Zhonghua Nan Ke Xue ; 18(3): 227-30, 2012 Mar.
Artigo em Chinês | MEDLINE | ID: mdl-22474987

RESUMO

OBJECTIVE: To study the effect of direct fumigation on the post-thaw recovery rate of cryopreserved spermatozoa, and to search for a best method for human sperm cryopreservation. METHODS: We collected semen samples from 100 donors conforming to the normal reference values in WHO Laboratory Manual for the Examination and Processing of Human Semen (5th Ed), divided them into two groups, and subjected them to cryopreservation by programmable freezing (Group A) and direct fumigation (Group B), respectively. We detected the progressive motility of pre-freezing and post-thaw sperm with a computer-assisted semen analyzer, and compared the effects of the two methods on the functional integrity of sperm membrane and the rate of abnormal sperm using the percentage of hypo-osmotic swelling sperm and modified Papanicolaou staining. RESULTS: Statistically significant differences were found in post-thaw sperm progressive motility between the Groups A and B ([34.0 +/- 18.4]% vs [43.0 +/- 19.5]%, P<0.05), both remarkably decreased as compared with pre-freezing ([57.0 +/- 16.7]%, P<0.05). Such differences were also found in the post-thaw recovery rate of progressively motile sperm between the two groups ([52.2 +/- 20.6]% vs [67.1 +/- 20.0]%, P<0.05). The post-thaw percentage of hypo-osmotic swelling sperm was obviously decreased in both Groups A and B ([67.1 +/- 11.1]% and [70.6 +/- 10.0]%) in comparison with pre-freezing ([84.5 +/- 7.5]%, P<0.05), with significant differences between A and B (P<0.05). However, the rate of sperm abnormality was evidently increased in Groups A and B ([85.0 +/- 8.7% and [85.7 +/- 9.1]%), significantly higher than pre-freezing ([77.8 +/- 9.6]%, P<0.05), but with no significant differences between A and B (P>0.05). CONCLUSION: Direct fumigation is superior to programmable freezing for its easier operation, wider application, and higher sperm recovery rate.


Assuntos
Criopreservação/métodos , Preservação do Sêmen/métodos , Espermatozoides , Adulto , Humanos , Masculino , Análise do Sêmen , Motilidade dos Espermatozoides , Adulto Jovem
6.
Chemosphere ; 81(11): 1463-8, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20869743

RESUMO

Cadmium is subject to significant Zr and Mo based oxide/hydroxide interferences in ICP-MS analysis of environmental samples. In this work, a dynamic reaction cell (DRC) technology was used to eliminate these metal oxide/hydroxide interferences. The potentially interfering ions (94)Zr(16)OH(+), (94)Mo(16)OH(+) and (95)Mo(16)O(+) on (111)Cd(+) were oxidized to higher oxides (94)ZrO(2)H(+)/(94)ZrO(3)H(+), (94)MoO(2)H(+)/(94)MoO(3)H(+), and (95)MoO(2)(+)/(95)MoO(3)(+) by O(2) as the reaction gas in DRC. Under the optimized O(2) flow rate (2.0 mLmin(-1)) and DRC rejection parameter q (Rpq, 0.75), the background signal was reduced by up to 100-fold at m/z 111 and the limit of quantitation (LOQ, 10σ) of 0.1 ngg(-1) was obtained. The proposed method was applied to direct analysis of trace Cd in a series of soil and sediment standard reference materials and the satisfactory results showed that it has great potential for the direct determination of trace or ultra-trace levels of cadmium in environmental samples.


Assuntos
Cádmio/análise , Monitoramento Ambiental/métodos , Poluentes Ambientais/análise , Cádmio/química , Poluentes Ambientais/química , Espectrometria de Massas , Oxirredução , Oxigênio/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA